• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-07-27

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal subpopulations, closely recapitulating the primary tumor microenvironment. The platform reveals how stromal diversity modulates gene expression and drug responses, offering a more physiologically relevant system for preclinical testing and personalized therapy design.

• Palonosetron Hydrochloride in CINV/RINV: Mechanistic and Cli

  2026-07-27

  The reference study offers a comprehensive evaluation of palonosetron hydrochloride’s unique pharmacological profile and its efficacy for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting (CINV/RINV). It highlights key innovations in receptor targeting and clinical outcomes that differentiate palonosetron from earlier 5-HT3 receptor antagonists, with direct implications for translational research and clinical practice.

• Aminopeptidase Inhibition Alters Angiotensin Signaling in Ra

  2026-07-26

  Harding and Felix’s study demonstrates that inhibiting brain aminopeptidases with bestatin and amastatin selectively modulates neuronal responses to angiotensin II and III. These findings clarify essential neuropeptide processing steps, with implications for experimental design in neurobiology and translational research.

• CHIR-99021 (CT99021): Catalyzing Advanced Human Stem Cell Mo

  2026-07-25

  Explore how CHIR-99021 (CT99021), a potent and selective GSK-3 inhibitor, enables translational researchers to engineer next-generation stem cell and neurovascular models with unprecedented mechanistic control. We blend mechanistic detail, experimental strategy, and cross-domain insight to empower innovation in the study of pluripotency, differentiation, and neuroimmune crosstalk. This article surpasses conventional product summaries by integrating new three-dimensional vascularized co-culture evidence, protocol guidance, and a translational outlook.

• PTGER4 Signaling Modulates HDAC Activity and SPINK4 in Recta

  2026-07-24

  Anbazhagan et al. (2024) elucidate how PTGER4 signaling, activated by mesenchymal stromal cell-derived PGE2, controls class IIa HDAC function and SPINK4 mRNA expression in rectal epithelial cells. This mechanistic insight advances understanding of epithelial homeostasis, with implications for mucosal injury and inflammatory bowel disease.

• Applied Workflows for Nicotinamide Adenine Dinucleotide (NAD

  2026-07-24

  Harness the unique properties of Nicotinamide Adenine Dinucleotide (NAD+) to streamline metabolic signaling and autophagy research. This guide details robust workflows, troubleshooting strategies, and the latest evidence-based insights—translating complex bench findings into actionable protocols with APExBIO’s high-purity NAD+.

• DMG-PEG2000-NH2: Enhancing Liposomal Drug Delivery Workflows

  2026-07-23

  DMG-PEG2000-NH2 empowers researchers to build more stable, biocompatible lipid nanoparticles and liposomes for drug and siRNA delivery. Its robust amide bond formation and high solubility streamline formulation and conjugation, making it a standout NH2-PEG derivative for reproducible, high-performance biomedical workflows.

• Topotecan (SKF104864): Mechanistic Impact and Strategic Visi

  2026-07-23

  This thought-leadership article explores the multifaceted role of Topotecan (SKF104864) in advancing translational oncology. By connecting mechanistic insights—such as topoisomerase I inhibition and DNA replication stress—with practical guidance for experimental design, it empowers researchers to implement robust, reproducible cancer models. The discussion highlights APExBIO’s research-grade Topotecan, integrates recent literature on glioma and pediatric tumor workflows, and frames a forward-looking vision for integrating DNA damage response strategies into the translational pipeline.

• Bradford Protein Assay Kit: Rapid, Sensitive Quantification

  2026-07-22

  The Bradford Protein Assay Kit addresses the need for fast, accurate, and reproducible protein concentration measurement in research workflows such as enzyme assays and molecular biology. It is suitable for users requiring rapid throughput and sensitivity down to 0.5 µg of protein, but may not be ideal for samples with interfering detergents or extreme pH. Researchers should follow protocol and quality control steps closely to ensure consistent results.

• ERAD-Hijacking Chimeras: A Platform for TM Protein Degradati

  2026-07-22

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a new technology that enables potent, selective degradation of transmembrane proteins by harnessing the ER-associated degradation (ERAD) pathway. This approach addresses longstanding challenges in targeted protein degradation and opens new avenues for both mechanistic research and therapeutic development.

• Methyl-β-cyclodextrin: Technical Use in Membrane Research

  2026-07-21

  Methyl-β-cyclodextrin (SKU C6939) is used to extract cholesterol and specific lipids from cellular membranes, supporting studies on membrane fluidity, lipid raft integrity, and cholesterol-dependent signaling. This reagent is designed for controlled laboratory research; it is not intended for clinical or diagnostic use.

• WY-14643 (Pirinixic Acid): Precision PPARα Agonist in Metabo

  2026-07-21

  WY-14643 (Pirinixic Acid) stands out as a benchmark tool for dissecting PPARα-mediated lipid metabolism, inflammation, and insulin sensitivity in both cellular and animal models. This article delivers advanced workflow tips, practical troubleshooting, and translational insights from the latest mechanistic research—empowering metabolic disorder and tumor microenvironment studies.

• SAR405 and the Vps34 Axis: Rethinking Autophagy Control

  2026-07-20

  This thought-leadership article dissects the evolving paradigm of autophagy regulation, focusing on the mechanistic role of Vps34 kinase and its selective inhibition by SAR405. By integrating recent findings that challenge the canonical AMPK–ULK1–autophagy axis, we provide translational researchers with strategic guidance for deploying SAR405 in complex disease models. The article differentiates itself by connecting advanced mechanistic insight, rigorous experimental design, and practical protocol recommendations—escalating the discussion beyond conventional product overviews and illuminating actionable paths for cancer and neurodegenerative research.

• EZ Cap™ Cre mRNA (m1Ψ): Optimizing Gene Editing Workflows

  2026-07-20

  The EZ Cap™ Cre mRNA (m1Ψ) streamlines high-fidelity gene editing, enabling efficient, low-immunogenic Cre recombinase expression in both in vitro and in vivo settings. With enhanced stability and translation efficiency, it is the go-to solution for precise, programmable gene editing in extrahepatic as well as traditional applications.

• Multiplexed Analysis of Avian Auditory Hair Cell Regeneratio

  2026-07-19

  This protocol paper presents a comprehensive workflow for in vivo elimination of avian auditory hair cells followed by multiplexed mRNA detection, immunohistochemistry, and S-phase labeling. The methods advance the study of sensory hair cell regeneration by enabling high-resolution, quantitative, and simultaneous analysis of gene and protein expression dynamics in the chicken inner ear.

452 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page